Jump to content
World's Largest Herpes Support Group


  • Donate

    If Honeycomb has helped you, please help us by making a donation so we can provide you with even better features and services.

  • The Hive is Thriving!

    • Total Topics
      71,381
    • Total Posts
      483,282
  • 0_unsure-if-it-is-herpes.png

    Nervous about dating with herpes? Skip "the talk" and browse profiles here.

  • Posts

    • Just a human being
      While I was wanting to take a break from my posting here for the next month as you asked a question I answered. Unfortunately while I can post and publish I cannot discuss the matter further here as I am being censored. That’s science for you. Endemic censorship and dishonesty. 
    • MikeHerp
      The HSV cure research is partly funded by the NIH. So it’s unlikely that FHC would stop it. If they stopped it, they couldn’t get the funding anymore. The cutbacks, while unfortunate, only affect 5% of their staff. Like any other private institution, they aren’t immune to the effects of a crashed economy. Let's continue to provide support and remain patient. Good news will cone but we have to be ready for the occasional setback or delay.  I will communicate with them about the status at the next opportunity,
    • WSX
      Leading by example — well done! Everyone else: Don't forget to check if your company matches charitable donations made out to Fred Hutch.
    • WilsoInAus
      Post flagged for moderation. Science is not censored, but fake material is censored and fraud is illegal. The article is a fake posted on an open source bulletin board - the bulletin board has no association with any university or research facility. There are no such people as Bernard Middleton or Susan Cosgrove, that is just part of the fraud. Nothing has ever been published concerning Synergy supplements. Why? Because they are just supplements that have never been shown to have any effect regarding herpes. There is no scientific reason why they would and no effect in any study has been found. Yes it is completely unreasonable to persist as you are and you have been warned for your behaviour by the moderator, I'm sure they will deal with appropriately.
    • Runner278
      I’m in for $1,000. 
Searching_Info

Phase 2 Trials of UB-621

Recommended Posts

WilsoInAus
2 hours ago, Searching_Info said:

All to early to say. 

Within the body, it is believed that cell-to-cell forms the key mechanism for how the virus can spread and replicate through your nerves. It is pretty well established that an infected cell binds to a neighbouring infected cell through a glycoprotein that exists on the outer membrane. This drug binds to this glycoprotein which in theory means there are no free glycoprotein receptors for herpes. This would mean less shedding if the theory works.

The real issue is does it work better than acyclovir which takes some beating.

Share this post


Link to post
Share on other sites
StayingUpbeat2

It depends on your definition of promising.  It is certainly an interesting addition to the treatment landscape.  It does not appear to be curative, simply another therapeutic.  It has a unique mechanism of action relative to the existing antivirals.  It therefore should be useful in situations when resistance to existing antivirals has arisen and have a synergistic effect with them. 

The major rub is that this treatment is an injection not a pill so the practicality is a bit thin relative to acyclovir and it's analogs.  It's also not clear how often it would need to be injected.  Judging from other mAb's something on the order of every  month would be likely.

Secondarily the treatment is in clinical trials in Taiwan so unless you're located there it will likely be a long time before it's available outside that country.

Share this post


Link to post
Share on other sites
Searching_Info

Thank you for your explanations.

One more thing, do you know why it's hard to find any mention of this therapeutic vaccine? Is it because it didn't go well in phase I clinical trials or pre clinical trials? It is not even mentioned in the wikipedia page but judging by some info I managed to find it seems like it's a big, well funded company.

Thanks in advance!

Share this post


Link to post
Share on other sites
The
On 5/31/2019 at 7:56 PM, Searching_Info said:

The trials have been moved to 2020 🤦‍♀️

https://clinicaltrials.gov/ct2/show/NCT01915212?term=NCT01915212&rank=1

Wrong link haha. Thats for the HSV529 vaccine.

 

√√

https://clinicaltrials.gov/ct2/show/NCT03595995

But yeah, UB-621 phase 2 trials start in 6 months. Make no mistake its not a vaccine, its a drug. That being said, I would easily take a monthly injection for suppressive therapy rather than chewing on daily antivirals. Curious to find out the efficacy results though...

Here's a chinese article that came out yesterday (translate button)

https://www.chinatimes.com/realtimenews/20190611001822-260410

 

Edited by The
Edit

Share this post


Link to post
Share on other sites
g480

Yes here is the English link: United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients

United BioPharma (UBP) announced the receipt of Investigational New Drug (IND) approval from the U.S. FDA to conduct a phase 2 clinical trial with UB-621 monoclonal antibody for recurrent genital infection caused by Herpes Simplex Virus, type II (HSV-2). UB-621 works to inhibit the infection through high-affinity binding to the same epitope on viral surface envelope gD protein on both type I (HSV-1) and type II (HSV-2) viruses.... Of interest to note as well, UB-621 binds to the same epitope on the gD envelope protein shared by both HSV-1 and HSV-2 viruses.  UB-621 has been shown in vitro to block HSV-1 infections of wild type and acyclovir-resistant viral strains with over hundreds-fold higher potency.  

http://www.unitedbiopharma.com/event_detail.php?id=367

 

Share this post


Link to post
Share on other sites
MiLoBeng

If they ever implement gene editing tech into vaccine. I'm pretty sure it'll produce better result than normal vaccine. 

Edited by MiLoBeng

Share this post


Link to post
Share on other sites
iFdUp
12 minutes ago, MiLoBeng said:

If they ever implement gene editing tech into vaccine. I'm pretty sure it'll produce better result than normal vaccine. 

Sounds like this could be HSV's equivalent to HIV's Laser ART. 

Share this post


Link to post
Share on other sites
LightafterDarkness

Just did a bit more reading here. This is another intriguing option that could work synergistically (1,2 punch)!

  • The Phase II study is currently slated to begin Jan 2020 AND it will be in the United States; I assume it will be done in the Seattle Area among other places
    • Note recruiting has not started but could be something to look into for folks on this board who are willing and able
  • Its going to be led by Anna Wald (which is a great sign since she is a heavy hitter in the field, presumably the phase I data had legs for her to sign up)
  • It looks like halflife of the treatment is 25 days
    • That is big because its been shown that treatments with longer half lives are needed (pritelivir shows a long half live as well; one weakness with valacyclovir is that very short)
  • This is not only for immunocompromised individuals
  • They will be measuring efficacy for suppression, shedding, etc. approx. 15 weeks post vaccination (so basically just shy of 4 months).
  • As others pointed above it works by binding (and thus blocking) to the same spot that a HSV virus would use to enter another cell
    • If I am understanding correctly this is a good thing as it basically means it can protect uninfected cells (pritelivir has a similar mechanism) which means it may be better than valacyclovir (since another weakness of the med is that it only kicks in on infected cells)

Assuming a start date of Jan 2020 I think realistically we dont hear anything in terms of results until end of 2020 / early 2021.

Share this post


Link to post
Share on other sites
Morty123

This is not a one shoot treatment, after few months monoclonal antibodies will disappear, you have to get every 3-4 months a shoot 

Share this post


Link to post
Share on other sites
LightafterDarkness

Yes- that is correct; it would be something you would need to take monthly or quarterly given the 25 day half life

Share this post


Link to post
Share on other sites
LightafterDarkness

Add this trial to the list of items scrambled by COVID

Current trial kickoff (with 80 participants) is set for June 1 after having been pushed back from earlier in the year. Hope this one is not upset even further.

https://clinicaltrials.gov/ct2/show/NCT03595995

Share this post


Link to post
Share on other sites
MikeHerp

Recruitment Status  : Not yet recruiting

 

Not sure when this study will really start.  Hope it does though.  

Share this post


Link to post
Share on other sites
MikeHerp

What I find interesting about this trial is that even though half life is 25 days, measurements of shedding and lesions will be done until nearly 4 months.  Maybe they expect the effect to last longer than the half life (maybe the binding effect survives longer than the half life). 

Share this post


Link to post
Share on other sites
WilsoInAus
5 hours ago, Graph14 said:

@MikeHerp is it’s application topical use?

Subcutaneous injection; a needle to the lower skin layers.

Share this post


Link to post
Share on other sites
MikeHerp

Right, it's an injection.  Not a topical.  It adds anti-HSV antibodies.

Share this post


Link to post
Share on other sites
dont quit!17
On 6/2/2020 at 1:18 PM, WilsoInAus said:

Subcutaneous injection; a needle to the lower skin layers.

Assuming, it is effective,  you can be trained to take those at home like a diabetic with insulin

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.